Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLS.L Regulatory News (SLS)

  • There is currently no data for SLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Standard Life UK Smaller Co's

1 May 2020 16:34

RNS Number : 7202L
Standard Life UK Small.Co's Tst PLC
01 May 2020
 

 

London, UK, 1 May 2020

Edison issues review on Standard Life UK Smaller Companies (SLS)

Standard Life UK Smaller Companies (SLS) is managed by Harry Nimmo at Aberdeen Standard Investments (ASI). He has a long-term record of meaningful outperformance versus the trust's benchmark. The manager has a clearly defined investment process, focusing on quality, growth and momentum, and uses a proprietary screening tool known as the Matrix to sift the investible universe of c 500 companies. Nimmo retains his disciplined approach regardless of the macro background; he says this has served him well across several market cycles. SLS's board has a progressive dividend policy and aims for a maximum 8% discount in normal market conditions.

 

SLS is currently trading at a 2.7% discount to cum-income NAV. This compares with the 6.0%, 5.6%, 5.9% and 4.6% average discounts over the last one, three, five and 10 years respectively. The FY19 annual dividend of 7.70p per share was 10% higher year-on-year, which was the largest increase in the last three years. SLS currently offers a 1.8% dividend yield, although it should be noted that c 60% of the trust's holdings have either suspended or deferred their dividends in recent weeks.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRABUGDUGXGDGGB
Date   Source Headline
18th Nov 20209:45 amRNSNet Asset Value(s)
18th Nov 20209:00 amRNSTransaction in Own Shares
17th Nov 20209:12 amRNSAppointment of Co Manager
16th Nov 20201:28 pmRNSGearing disclosure
16th Nov 20201:14 pmRNSNet Asset Value(s)
13th Nov 202012:24 pmRNSNet Asset Value(s)
13th Nov 202012:00 pmRNSPortfolio disclosure
12th Nov 202010:56 amRNSNet Asset Value(s)
11th Nov 202011:13 amRNSNet Asset Value(s)
10th Nov 202011:18 amRNSNet Asset Value(s)
9th Nov 20205:55 pmRNSTransaction in Own Shares
9th Nov 20202:33 pmRNSGearing disclosure
9th Nov 202012:12 pmRNSNet Asset Value(s)
6th Nov 202011:40 amRNSNet Asset Value(s)
5th Nov 20205:10 pmRNSTransaction in Own Shares
5th Nov 20201:59 pmRNSMonth End Net Asset Value(s)
5th Nov 202011:13 amRNSNet Asset Value(s)
4th Nov 202012:20 pmRNSNet Asset Value(s)
3rd Nov 20202:12 pmRNSNet Asset Value(s)
2nd Nov 20202:37 pmRNSGearing disclosure
2nd Nov 202011:14 amRNSTotal Voting Rights
2nd Nov 20209:59 amRNSBlock listing Interim Review
30th Oct 202012:44 pmRNSNet Asset Value(s)
29th Oct 20205:09 pmRNSTransaction in Own Shares
29th Oct 202012:39 pmRNSNet Asset Value(s)
28th Oct 20205:20 pmRNSTransaction in Own Shares
28th Oct 202012:20 pmRNSNet Asset Value(s)
27th Oct 20205:03 pmRNSTransaction in Own Shares
27th Oct 202011:02 amRNSNet Asset Value(s)
26th Oct 20205:07 pmRNSTransaction in Own Shares
26th Oct 20203:27 pmRNSGearing Disclosure
26th Oct 202012:30 pmRNSNet Asset Value(s)
23rd Oct 20201:44 pmRNSNet Asset Value(s)
22nd Oct 202012:56 pmRNSNet Asset Value(s)
21st Oct 20202:06 pmRNSResult of AGM
21st Oct 202012:03 pmRNSNet Asset Value(s)
20th Oct 202011:51 amRNSNet Asset Value(s)
19th Oct 202012:35 pmRNSNet Asset Value(s)
16th Oct 202012:27 pmRNSNet Asset Value(s)
15th Oct 202012:38 pmRNSNet Asset Value(s)
15th Oct 202011:07 amRNSPortfolio disclosure
14th Oct 202011:58 amRNSNet Asset Value(s)
13th Oct 202011:10 amRNSNet Asset Value(s)
12th Oct 20201:53 pmRNSGearing disclosure
12th Oct 202012:12 pmRNSNet Asset Value(s)
9th Oct 202011:24 amRNSNet Asset Value(s)
8th Oct 202011:45 amRNSNet Asset Value(s)
7th Oct 202012:59 pmRNSNet Asset Value(s)
6th Oct 20204:10 pmRNSMonth End Net Asset Value(s)
6th Oct 202012:54 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.